For a side-by-side comparison of the two individual compounds, see: BPC-157 vs TB-500
Immunotherapy is the newest and most promising type of therapeutic for cancer right now, but even so, immune checkpoint inhibitors have failed to do much against most solid tumors, including prostate cancer
Research Findings The research foundation for Epithalon is substantial, though much of this work has been conducted in Russia and published primarily in Russian or Eastern European journals, with less representation in mainstream Western scientific literature
Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats
National Academy Press Washington, D.C
2 The current treatment for IDD is based on a stepwise treatment paradigm largely limited to symptomatic relief using nonsteroidal or steroidal medication